ICBB 2023 - 2023 International Conference on Biotechnology and Bioengineering (13th ICBB)
Website https://www.icbb.apaset.edu.pl/ |
Edit Freely
Category biotechnology; bioengineering; molecular biology; immunology, pharmacology
Deadline: August 31, 2023 | Date: September 28, 2023-October 01, 2023
Venue/Country: Italy
Updated: 2023-02-01 16:12:38 (GMT+9)
Call For Papers - CFP
On behalf of the Organizing Committee, it is our great pleasure to welcome you to participate in the 2023 International Conference on Biotechnology and Bioengineering (13th ICBB, 2023) to be held during Sept. 28-Oct. 1, 2023. Website: https://www.icbb.apaset.edu.pl/
[Organizers]ICBB2023 is co-organized by Asia-Pacific Association of Science Engineering and Technology, Institute of Biomolecular Chemistry-National Research Council of Italy, Institute of Bioorganic Chemistry-Polish Academy of Sciences, and Chinese Journal of Biologicals, in collaboration with multiple academic affiliations.[Aims and Topics]ICBB2023 aims to provide an innovative and comprehensive overview of BIOTECHNOLOGY and BIOENGINEERING, a focus will be given to major research advances including: 1. Microbiology, virology, cytology and immunology; 2. Biological macromolecules, proteins and nucleic acids; 3. Biomaterials, biopolymers and bioenergy; 4. Biomedicine, biopharmaceuticals, pharmacology and toxicology; 5. Agricultural & food science and industrial biotechnology; 6. Applications in bioengineering, biomedical engineering & technology and other related fields.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.